This guide explains published facts and prices. It is not medical advice: a licensed provider who knows your health history decides what is right for you.
Is semaglutide the same as Ozempic?
Ozempic is one brand of semaglutide. Wegovy and Rybelsus are others, and each brand's label lists its own approved uses:
- Ozempic injection: for adults with type 2 diabetes, to improve blood sugar control along with diet and exercise; to reduce the risk of major cardiovascular events (cardiovascular death, non-fatal heart attack or non-fatal stroke) in those who also have established cardiovascular disease; and to reduce the risk of a sustained drop in kidney function (eGFR decline), end-stage kidney disease and cardiovascular death in those who also have chronic kidney disease (Ozempic prescribing information).
- Rybelsus and Ozempic tablets: to improve blood sugar control in adults with type 2 diabetes, along with diet and exercise (Rybelsus and Ozempic tablets prescribing information).
- Wegovy injection: along with a reduced-calorie diet and more physical activity, to reduce excess body weight and keep it off long term in adults and children 12 and older with obesity, and in adults with overweight and at least one weight-related health condition; and to reduce the risk of major cardiovascular events in adults with established cardiovascular disease and either obesity or overweight (Wegovy prescribing information).
- Wegovy tablets: the same uses, in adults only (Wegovy prescribing information).
So "semaglutide" on a price list does not tell you which brand it is, or whether it is a brand at all. Ask.
How is semaglutide taken?
The Wegovy label sets out its schedule like this (Wegovy prescribing information):
- Wegovy injection: once a week, on the same day each week, at any time of day, with or without meals, alongside diet and more physical activity.
- Starting dose: 0.25 mg once a week for 4 weeks, then stepped up every 4 weeks on the label's schedule until you reach the maintenance dose.
- Usual maintenance dose of the injection: 2.4 mg once a week.
- Wegovy tablet: started at 1.5 mg once a day for 30 days.
Ozempic and Rybelsus have their own labels, so ask your provider for the schedule of the product you are prescribed, and what comes after the first 30 days of tablets.
What did the semaglutide weight loss trial find?
In a trial published in 2021, 1,961 adults without diabetes were randomly assigned, two to one, to 68 weeks of once-weekly semaglutide 2.4 mg injections under the skin or a placebo, with a lifestyle program for both groups. Each had a body-mass index (BMI) of 30 or more, or 27 or more with at least one weight-related health condition (New England Journal of Medicine, 2021).
By week 68, people on semaglutide had lost an average of 14.9% of their starting body weight, compared with 2.4% on placebo. Nausea and diarrhea were the most common side effects with semaglutide; they were usually short-lived and mild to moderate, and they eased with time (New England Journal of Medicine, 2021).
An average is not a forecast for one person. Ask your provider what the results mean for you.
Is semaglutide safe?
The Wegovy label answers with facts, not a yes or a no: who it is approved for, which is above, and these warnings, which a licensed provider weighs for you (Wegovy prescribing information):
- Boxed warning: in rodents, semaglutide causes thyroid C-cell tumors, more often at higher doses and with longer treatment, at exposures relevant to treatment. It is unknown whether Wegovy causes these tumors, including medullary thyroid carcinoma (MTC), in humans, because the human relevance of the rodent tumors has not been determined.
- Who must not take it: anyone with a personal or family history of MTC or with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), and anyone who has had a serious allergic reaction to semaglutide or to any of the inactive ingredients in Wegovy.
- Other warnings: acute pancreatitis (inflammation of the pancreas), acute gallbladder disease, low blood sugar, acute kidney injury from loss of body fluids, severe digestive side effects, allergic reactions, complications of diabetic retinopathy (diabetes-related eye disease) in people with type 2 diabetes, a rise in heart rate, and pulmonary aspiration (breathing stomach contents into the lungs) during general anesthesia or deep sedation.
- Other GLP-1 medicines: using Wegovy with other semaglutide products or with any other GLP-1 receptor agonist is not recommended.
- Pregnancy: weight loss offers no benefit during pregnancy and may harm the unborn baby, and the label says to stop Wegovy at least 2 months before a planned pregnancy, because semaglutide stays in the body a long time.
The label's most common side effects, reported in at least 5% of adults or children 12 and older, are nausea, diarrhea, vomiting, constipation, abdominal pain, dysesthesia (unpleasant, abnormal sensations), headache, fatigue, indigestion, dizziness, bloating, burping, low blood sugar in people with type 2 diabetes, gas, gastroenteritis (inflammation of the stomach and intestines), acid reflux and hair loss (Wegovy prescribing information).
What about compounded semaglutide?
A med spa's monthly semaglutide price may not be for Ozempic, Wegovy or Rybelsus. FDA has raised these concerns about semaglutide in particular (FDA's concerns with unapproved GLP-1 drugs):
- FDA received multiple reports of health problems, some requiring a hospital stay, that may be related to dosing errors with compounded semaglutide injections. The errors came from patients measuring and giving themselves the wrong dose, and in some cases from health care professionals miscalculating the dose.
- FDA says salt forms of semaglutide, such as semaglutide sodium and semaglutide acetate, are different active ingredients from those used in the approved drugs.
- FDA is aware of counterfeit Ozempic marketed in the U.S.
So ask whether the product is FDA approved or compounded, which form of semaglutide it contains, how each dose is measured, and where the medication comes from. FDA's broader concerns about compounded and unapproved GLP-1 drugs are in what is a GLP-1.
What does semaglutide cost at a Georgia med spa?
These are estimates from what Georgia med spas and skin clinics publish, not quotes, and we do not name any company.
- Semaglutide, monthly program: estimated at $150 to $310+ per month. See what a month of semaglutide covers.
- Consultation before you start: estimated at $75 to $100+, where a med spa charges one. See consultation fees.
For how semaglutide compares with tirzepatide, in price and in the research, read semaglutide or tirzepatide.
Questions to ask your provider
- Which brand is this, or is it compounded?
- If it is compounded, which form of semaglutide is it, and which pharmacy fills it?
- How is each dose measured, and who shows me how to take it?
- Which warnings on the label apply to me?
- What will each month cost as the dose goes up?
Ask for the brand or product name and each month's price in writing before you start.
Sources
- Wegovy (semaglutide) injection and tablets, FDA-approved prescribing information (Novo Nordisk, label effective June 2026), DailyMed, National Library of Medicine
- Ozempic (semaglutide) injection, FDA-approved prescribing information (Novo Nordisk, label effective June 2026), DailyMed, National Library of Medicine
- Rybelsus and Ozempic (oral semaglutide) tablets, FDA-approved prescribing information (Novo Nordisk, label effective January 2026), DailyMed, National Library of Medicine
- Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine. 2021;384(11):989-1002
- FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss, U.S. Food and Drug Administration
Prices mentioned here come from our Georgia med spa cost ranges, built from the prices and cost guides Georgia med spas publish on their public websites, collected September and October 2026.